Note: Unless otherwise stated, all variations indicated below are on an unaudited like-for-like basis, ie, at constant currency and perimeter. The variation is calculated as follows: i) H1 2024-25 USD ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules “These strategic achievements came alongside solid financial results, as demonstrated by strong double-digit growth in ...
2Q25 2Q25 vs vs 2Q25 1Q25 2Q24 2Q24 Cash flow from operations excluding working capital (CFFO)(1) (B$) 6.6 -5% 13.6 -15% Adjusted net income (TotalEnergies share)(1) - in billions of dollars (B$) 3.6 ...
Net banking income stood at EUR 6.8 billion, up +1.6% vs. Q2 24 and +7.1% excluding asset disposals. The Corporate Centre recorded revenues of EUR -160 million in Q2 25. In the first half of the year, ...
• Quarterly record revenue in Q2 of $21M, +43% year-over-year growth; IFRS gross margin of 75.5% • Second quarter pulse recurring revenue of $9.2M, +53% year-over-year growth • First half revenue of ...
SAN CARLOS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor ...
The Board of Directors of Eutelsat Communications (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL), chaired by Dominique D’Hinnin, reviewed the financial results for the Half Year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results